Nuclea USA, Mangoceuticals merger partner subsidiary, signs Utah energy office MOU on microreactor test site
MGRX•Deal context
The agreement follows a definitive business combination agreement between Mangoceuticals and Nuclea announced July 30, 2026.
Regulatory and federal engagement
The MOU also supports engagement with the U.S. Department of Energy and Nuclear Regulatory Commission to advance demonstration and deployment.
MOU on Utah microreactor test site
Nuclea Energy USA, a wholly owned unit of Mangoceuticals’ merger partner Nuclea Energy, signed an MOU with Utah’s Office of Energy Development.
The deal targets exploration of siting a nuclear test reactor at the Utah San Rafael Energy Lab for Nuclea’s Morpheus microreactor.
